Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$579,958,037
+$150,720,694 QoQ
Shares Held
483,528
+3.6% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#127
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clearbridge Investments, LLC holds $3,156,802,100 across 12 Drug Manufacturers - General names. LLY ranks #3 (18.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,343,260 | $1,357,027,741 | |
| 2 | AZN |
Astrazeneca PLC
|
5,021,518 | $952,180,243 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
483,528 | $579,958,037 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,088,957 | $137,578,827 | |
| 5 | MRK |
Merck & Co., Inc.
|
565,690 | $72,691,165 | |
| 6 | AMGN |
Amgen Inc
|
69,065 | $25,009,817 | |
| 7 | ABBV |
AbbVie Inc.
|
82,422 | $20,740,672 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
101,597 | $5,854,019 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $579,958,037 | 483,528 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $429,237,343 | 466,679 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $405,934,615 | 377,726 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $292,320,560 | 383,120 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $719,188,920 | 922,593 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $840,517,870 | 1,017,687 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $844,642,112 | 1,094,096 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,029,173,463 | 1,161,674 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,024,860,282 | 1,131,967 | Shares | Sole | 2024-08-27 | |
| 2024-03-31 | $881,336,101 | 1,132,881 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $565,993,751 | 970,963 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $510,803,647 | 950,987 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $451,743,578 | 963,247 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $334,336,541 | 973,550 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $111,998,257 | 306,140 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $99,318,569 | 307,155 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $100,457,153 | 309,833 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $88,575,100 | 309,303 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $102,331,775 | 370,472 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $116,594,992 | 504,631 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $120,688,042 | 525,828 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $105,589,356 | 565,193 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $88,164,702 | 522,179 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $5,590,419 | 37,768 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,213,864 | 31,757 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,088,674 | 7,848 | Shares | Defined | 2020-05-22 | |
| No filing history on record for this holder in this stock. | ||||||